Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP3315124

BILAYER TABLET FORMULATIONS

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    12.11.2010
  • EP published:
    6.1.2021
  • EP application number:
    17206106.1
  • Max expiry date:
    11.11.2030
  • Title:
    BILAYER TABLET FORMULATIONS

Timeline

Today
12.11.2010EP application
6.1.2021EP Publication

Owner

  • Name:
    Astrazeneca AB
  • Address:
    151 85 Södertälje, SE
  • Name:
    AstraZeneca UK Limited
  • Address:
    1 Francis Crick Avenue, Cambridge Biomedical Campus Cambridge CB2 0AA, GB

Inventor

  • Name:
    ABEBE, Admassu
  • Address:
    Princeton, NJ 08543, US
  • Name:
    MARTIN, Kyle
  • Address:
    Princeton, NJ 08543, US
  • Name:
    PATEL, Jatin M.
  • Address:
    Princeton, NJ 08543, US
  • Name:
    DESAI, Divyakant
  • Address:
    Princeton, NJ 08543, US
  • Name:
    TIMMINS, Peter
  • Address:
    Princeton, NJ 08543, US

Priority

  • Number:
    261087 P
  • Date:
    13.11.2009
  • Country:
    US

Classification

  • Categories:
    A61K 9/24, A61K 31/155, A61K 31/70, A61K 31/7034, A61K 31/7042, A61K 31/7004, A61K 31/403, A61K 45/06, A61P 3/00, A61P 3/04, A61P 3/06, A61P 3/10, A61P 5/50, A61P 9/10, A61P 9/12, A61P 13/12, A61P 17/02, A61P 25/00, A61P 27/02, A61P 27/12, A61P 43/00, A61K 9/20

Upload documents